These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4920529)

  • 1. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antigenic structure of the toxins of Clostridium botulinum, type C strains, isolated in the USSR].
    Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Aug; 42(8):79-84. PubMed ID: 5334428
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of Clostridium boltulinum toxins using passive hemagglutination].
    Franke F
    Zentralbl Veterinarmed B; 1974 Sep; 21(9):660-76. PubMed ID: 4619737
    [No Abstract]   [Full Text] [Related]  

  • 8. The toxic antigenic factors produced by Clostridium botulinum types C and D.
    Jansen BC
    Onderstepoort J Vet Res; 1971 Jun; 38(2):93-8. PubMed ID: 4950122
    [No Abstract]   [Full Text] [Related]  

  • 9. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of type F Clostridium botulinum. IV. Serological properties of soluble and insoluble antigens].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(1):13-20. PubMed ID: 4986009
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological analysis of spores of Clostridium botulinum type E.
    Law SW; Hawirko RZ
    Can J Microbiol; 1969 Dec; 15(12):1427-31. PubMed ID: 4983961
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification and some properties of Clostridium botulinum type-E toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochim Biophys Acta; 1968 Oct; 168(2):207-17. PubMed ID: 4972262
    [No Abstract]   [Full Text] [Related]  

  • 18. [An immunochemical study of serologically active substances isolated from Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):10-8. PubMed ID: 4969441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunogenic activity of the combined botulinum toxoids].
    Trembowler P; Switalska A; Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(2):161-8. PubMed ID: 4913814
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study of botulin toxins and anatoxins by the gel filtration method. I. Studies of botulin toxins and anatoxins types A and C by filtration through Sephadex G-100].
    Freĭman VB; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):52-8. PubMed ID: 4975811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.